Azelaic Acid (20% w/w) is a topical dicarboxylic acid with potent comedolytic, anti-inflammatory, antibacterial, and mild depigmenting properties. It is a first-line treatment for mild-to-moderate inflammatory acne vulgaris and is highly effective for treating papulopustular rosacea. It is well-tolerated with a favorable safety profile, making it suitable for long-term use, including in pregnancy (under medical supervision). Its mechanism is multi-factorial, targeting the primary pathogenic factors of acne and hyperpigmentation.
Adult: Apply a thin layer to the affected area(s) twice daily, morning and evening. For rosacea, apply after cleansing and drying the face.
Note: 1. Wash and pat dry the affected area. 2. Apply a pea-sized amount for the entire face or a thin layer to larger areas. 3. Gently massage into the skin until absorbed. 4. Wash hands after application. 5. May be used under non-comedogenic moisturizers and sunscreen. For acne, it can be applied after a topical retinoid (if tolerated, with a time gap).
Azelaic Acid exerts its therapeutic effects through multiple complementary mechanisms: 1) Antimicrobial: Inhibits the synthesis of microbial cellular proteins, leading to bacteriostatic activity against Cutibacterium acnes and Staphylococcus epidermidis. 2) Anti-keratinizing/Normalizing: Normalizes the disturbed terminal differentiation of keratinocytes within the follicular infundibulum, reducing microcomedone formation. 3) Anti-inflammatory: Scavenges reactive oxygen species (ROS) and inhibits the production of pro-inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6) and free radicals by neutrophils. 4) Depigmenting: Competitively inhibits tyrosinase, the key enzyme in melanin synthesis, and exerts cytotoxic effects on hyperactive and abnormal melanocytes (e.g., in melasma), while sparing normal melanocytes.
Pregnancy: Category B (Indian/US FDA). Animal studies have shown no fetal risk; no adequate, well-controlled studies in pregnant women. Topical use is generally considered low risk due to minimal absorption. Should be used only if clearly needed and under medical supervision.
Driving: No effect on ability to drive or use machines.
| Topical Retinoids (Tretinoin, Adapalene, Tazarotene) | Increased potential for skin irritation, dryness, and peeling. Sequential application with a time gap (e.g., retinoid at night, azelaic acid in morning) is advised. | Moderate |
| Topical Benzoyl Peroxide | Concomitant use may increase irritation. Can be used sequentially (e.g., one in AM, other in PM) if tolerated. | Moderate |
| Topical Salicylic Acid, Other AHAs/BHAs | Increased risk of irritation and skin barrier disruption. Introduce cautiously. | Moderate |
| Topical Hydroquinone | May be used in combination for hyperpigmentation under supervision, but monitoring for excessive irritation is crucial. | Moderate |
| Abrasive or Highly Astringent Cosmetics/Skin Cleansers | Increased likelihood of irritation. Use mild, non-comedogenic products. | Mild |